- Home
- SMPL vs APGE Comparison
SMPL vs APGE Comparison
Compare SMPL & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMPL
- APGE
- Stock Information
- Founded
- SMPL 2017
- APGE 2022
- Country
- SMPL United States
- APGE United States
- Employees
- SMPL N/A
- APGE N/A
- Industry
- SMPL Packaged Foods
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SMPL Consumer Staples
- APGE Health Care
- Exchange
- SMPL Nasdaq
- APGE Nasdaq
- Market Cap
- SMPL 3.4B
- APGE 3.0B
- IPO Year
- SMPL 2016
- APGE 2023
- Fundamental
- Price
- SMPL $38.35
- APGE $47.45
- Analyst Decision
- SMPL Buy
- APGE Strong Buy
- Analyst Count
- SMPL 9
- APGE 6
- Target Price
- SMPL $40.22
- APGE $75.40
- AVG Volume (30 Days)
- SMPL 844.9K
- APGE 623.0K
- Earning Date
- SMPL 01-09-2025
- APGE 11-12-2024
- Dividend Yield
- SMPL N/A
- APGE N/A
- EPS Growth
- SMPL 4.55
- APGE N/A
- EPS
- SMPL 1.38
- APGE N/A
- Revenue
- SMPL $1,331,321,000.00
- APGE N/A
- Revenue This Year
- SMPL $11.92
- APGE N/A
- Revenue Next Year
- SMPL $6.11
- APGE N/A
- P/E Ratio
- SMPL $27.79
- APGE N/A
- Revenue Growth
- SMPL 7.13
- APGE N/A
- 52 Week Low
- SMPL $30.00
- APGE $25.85
- 52 Week High
- SMPL $43.00
- APGE $72.29
- Technical
- Relative Strength Index (RSI)
- SMPL 46.94
- APGE 49.00
- Support Level
- SMPL $39.21
- APGE $43.69
- Resistance Level
- SMPL $40.32
- APGE $48.85
- Average True Range (ATR)
- SMPL 0.71
- APGE 3.97
- MACD
- SMPL -0.30
- APGE 0.26
- Stochastic Oscillator
- SMPL 3.44
- APGE 48.79
About SMPL The Simply Good Foods Company
The Simply Good Foods Co is a consumer packaged food and beverage company. It provides low-carbohydrate, high protein bars, shakes, and other products such as confections, chips, and cookies under the Atkins and Quest brands. The company distributes its products in retail channels, predominantly in North America, including grocery, club, and mass merchandise, as well as through e-commerce, convenience, and other channels.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.